This site is intended for health professionals only!

Published on 22 June 2007

Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Conference aims to boost biotech
EMEA tightens up on rosiglitazone label
New €250m facility will bring Geel workforce to 600
Watchdog rejects arthritis drug appeal
Is there a need for testosterone replacement therapy in older men?

US go-ahead for Exforge

teaser

Novartis has received US approval for Exforge



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
User-friendly osteoporosis therapy launched
4
Merck agrees huge Vioxx settlement
5
Janssen-Cilag’s Stelara approved by NICE



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Treatment advances in adrenocortical carcinoma
GIA announces the release of a comprehensive global report on Lung Cancer Therapeutics marke
Pfizer wins legal fight on Celebrex
New drug combination may reduce breast cancer
SC mAbs: remodelling traditional anticancer therapy